Overview
Job Description
Myriad Genetics is seeking a Senior Manager, Omnichannel Marketing to lead the development, execution, and measurement of marketing campaigns that drive growth across Myriad’s Oncology portfolio. You will be responsible for leading and driving results for a team of downstream marketing professionals. You will collaborate with numerous internal and external teams including but not limited to sales, operations, medical, enterprise marketing, and advertising agency partners. You will lead strategy execution across all channels, creating campaigns and deliverables (launch and execution) to reach target audiences which includes surgeons, oncologists, genetic counselors, and patients. This person must understand the digital landscape and know how to build a cohesive content strategy across all channels. The ideal candidate will have worked in a sales-driven organization and is a strong but empathetic leader experienced in leading a high performing team. **
Responsibilities**
Qualifications
Physical Requirements
Lifting Requirements – light work or exerting up to 20 pounds of force frequently. Physical Requirements – stationary positioning, moving, operating, ascending/descending, communicating, and observing. Use of equipment and tools necessary to perform essential job functions. **
EEO**
We recognize that our people are our strength and the diverse talents they bring to our global workforce are directly linked to our success. We are an equal opportunity employer and place a high value on diversity and inclusion at our company. In hiring and all other employment decisions, we prohibit discrimination and harassment on the basis of any protected characteristic, including race, religion, color, national origin, gender, sexual orientation, gender identity, gender expression, age, marital or veteran status, pregnancy or disability, or any other basis protected under applicable law. In accordance with applicable law, we make reasonable accommodations for applicants’ and employees’ religious practices and beliefs, as well as any mental health or physical disability needs. **
About Us**
Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. For more information on how Myriad is making a difference, please visit the Company's website: www.myriad.com .
We recognize that our people are our strength and the diverse talents they bring to our global workforce are directly linked to our success. We are an equal opportunity employer and place a high value on diversity and inclusion at our company. In hiring and all other employment decisions, we prohibit discrimination and harassment on the basis of any protected characteristic, including race, religion, color, national origin, gender, sexual orientation, gender identity, gender expression, age, marital or veteran status, pregnancy or disability, or any other basis protected under applicable law. In accordance with applicable law, we make reasonable accommodations for applicants’ and employees’ religious practices and beliefs, as well as any mental health or physical disability needs.
Please answer all questions completely. Please do not provide any information not specifically requested on this Employment Application form. **
Organization**
Myriad Oncology, a business unit of Myriad Genetics focuses on three products EndoPredict®, BRACAnalysis CDx® and The Myriad myRisk® Hereditary Cancer. EndoPredict® can help accurately determine an individual patient’s 10-year risk of recurrence to help physicians identify which patients may consider safely forgoing chemotherapy.BRACAnalysis CDx® is an FDA-approved laboratory developed test for BRCA1 and BRCA2 intended to inform patient management related to the PARP inhibitors, Lynparza® (olaparib) and Zejula® (niraparib). The Myriad myRisk® Hereditary Cancer test is a multi-gene panel that identifies an elevated risk for eight hereditary cancers: Blending both genetic test status AND personal cancer family history, Myriad myRisk hereditary cancer panel represents the next generation of hereditary cancer risk testing.
Edward Jones
Paired
Lyreco Group
Talentuch
Mambu